(±)-CPSI-1306

• UNSPSC Description:

  (±)-CPSI-1306 is an orally available antagonist of macrophage migration inhibitory factor (MIF).

• Target Antigen:

  Macrophage migration inhibitory factor (MIF)

• Type:

  Reference compound

• Related Pathways:

  Immunology/Inflammation

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Metabolic Disease; Inflammation/Immunology

• Assay Protocol:

  https://www.medchemexpress.com/__plusmn__-CPSI-1306.html

• Purity:

  98.90

• Solubility:

  DMSO : 6 mg/mL (ultrasonic)

• Smiles:

  FC1=C(C=CC(F)=C1)C2=NOC(CC(N3CCOCC3)=O)C2

• Molecular Weight:

  310.30

• References & Citations:

  [1]Sanchez-Zamora Y, et al. Macrophage migration inhibitory factor is a therapeutic target in treatment of non-insulin-dependent diabetes mellitus. FASEB J. 2010 Jul;24(7):2583-90.|[2]Nagarajan P, et al. MIF antagonist (CPSI-1306) protects against UVB-induced squamous cell carcinoma. Mol Cancer Res. 2014 Sep;12(9):1292-302.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  -20°C, 3 years; 4°C, 2 years (Powder)

• Clinical Information:

  No Development Reported

• CAS Number:

  1309793-47-2